QTTBQ32 Bio Inc.

QTTB Stock Price, Valuation & Chart | Q32 Bio Inc.

Compare

$13.590-0.77 (-5.36%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Biotechnology QTTB intrinsic value QTTB calculated fair value vs price

Overview Financials Dividends Ratios

QTTB Historical price chart

QTTB Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization404.49M

PE Ratio6.57

EPS2.07

Trading Volume433.31K

Today's High/Low14.55/13.35

Dividend Yield0.00

52 Week High/Low23.57/1.62

Shares Outstanding29.76M

QTTB Financial Statement

QTTB Analyst ratings

QTTB Analysis & performance metrics

QTTB Company profile

Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases…

Q32 Bio Inc., a clinical-stage biotechnology company, develops biologic therapeutics to restore healthy immune balance in patients with autoimmune and inflammatory diseases driven by pathological immune dysfunction in the United States. Its lead product candidate is ADX-097, a humanized anti-C3d monoclonal antibody fusion protein to restore complement regulation, which has completed…

QTTB Management team

Name

Position

Maria Marzilli M.P.H.

Executive Vice President of Corporate Strategy & Program Operations

David Appugliese J.D.

Senior Vice President & Head of People

Saul W. Fink Ph.D.CTO

Chief Technology Officer

Jason A. Campagna M.D., Ph.D.

Chief Medical Officer

Shelia M. Violette Ph.D.

Co-founder, Chief Scientific Officer & President of Research

Jodie Pope MorrisonCEO

Chief Executive Officer & Director

Lee H. Kalowski M.B.A.CFO

Chief Financial Officer & President

Name

Position

Maria Marzilli M.P.H.

Executive Vice President of Corporate Strategy & Program Operations

David Appugliese J.D.

Senior Vice President & Head of People

Saul W. Fink Ph.D.CTO

Chief Technology Officer

Jason A. Campagna M.D., Ph.D.

Chief Medical Officer

Shelia M. Violette Ph.D.

Co-founder, Chief Scientific Officer & President of Research

Jodie Pope MorrisonCEO

Chief Executive Officer & Director

Lee H. Kalowski M.B.A.CFO

Chief Financial Officer & President

Management Team

Maria Marzilli M.P.H.

Executive Vice President of Corporate Strategy & Program Operations

David Appugliese J.D.

Senior Vice President & Head of People

Saul W. Fink Ph.D.CTO

Chief Technology Officer

Jason A. Campagna M.D., Ph.D.

Chief Medical Officer

Shelia M. Violette Ph.D.

Co-founder, Chief Scientific Officer & President of Research

Jodie Pope MorrisonCEO

Chief Executive Officer & Director

Lee H. Kalowski M.B.A.CFO

Chief Financial Officer & President

Management

Maria Marzilli M.P.H.

Executive Vice President of Corporate Strategy & Program Operations

David Appugliese J.D.

Senior Vice President & Head of People

Saul W. Fink Ph.D.CTO

Chief Technology Officer

Jason A. Campagna M.D., Ph.D.

Chief Medical Officer

Shelia M. Violette Ph.D.

Co-founder, Chief Scientific Officer & President of Research

Jodie Pope MorrisonCEO

Chief Executive Officer & Director

Lee H. Kalowski M.B.A.CFO

Chief Financial Officer & President

Total 7 executives

QTTB Frequently asked questions

What is Q32 Bio Inc. (QTTB) Stock Price?

Current stock price of Q32 Bio Inc. (QTTB) stock is $13.590. The stock price is -5.36% lower in the session. The intraday range can be seen from this page. Volume of Q32 Bio Inc. (QTTB) stock is 433.31K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Q32 Bio Inc. (QTTB) stock price going up or down today?

The stock price of Q32 Bio Inc. (QTTB) can change with earnings, company news, and overall market sentiment. Q32 Bio Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Q32 Bio Inc. stock expensive at its current price?

Whether Q32 Bio Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for QTTB on this page is 6.57. EPS on this page is 2.07. Compare those figures with peers and growth expectations before deciding if the current Q32 Bio Inc. price is justified.

How has the stock price of Q32 Bio Inc. (QTTB) performed historically?

Historical performance for Q32 Bio Inc. (QTTB) is shown on the price chart on this page. Review multi-period moves alongside volume to see how QTTB reacted to past earnings and market events.

Should I buy Q32 Bio Inc. (QTTB) stock, at this price?

Buying Q32 Bio Inc. (QTTB) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.